Full metadata record
DC FieldValueLanguage
dc.contributor.authorALLEN Barry J.en_GB
dc.contributor.authorRAJA C.en_GB
dc.contributor.authorRIZVI S.m.a.en_GB
dc.contributor.authorLI Y.en_GB
dc.contributor.authorTSUI W.en_GB
dc.contributor.authorGRAHAM P.en_GB
dc.contributor.authorTHOMPSON J.en_GB
dc.contributor.authorREISFELD R.a.en_GB
dc.contributor.authorKEARSLEY J.en_GB
dc.contributor.authorMORGENSTERN ALFREDen_GB
dc.contributor.authorAPOSTOLIDIS CHRISTOSen_GB
dc.date.accessioned2010-02-25T14:47:01Z-
dc.date.available2006-06-01en_GB
dc.date.available2010-02-25T14:47:01Z-
dc.date.issued2005en_GB
dc.date.submitted2006-05-31en_GB
dc.identifier.citationCANCER BIOLOGY & THERAPY vol. 4 p. 1318-1324en_GB
dc.identifier.urihttp://publications.jrc.ec.europa.eu/repository/handle/JRC33607-
dc.description.abstractThe paper reports the development and application of intralesional targeted alpha therapy (TAT) for melanoma, being the first part of a program to establish a new systemic therapy.en_GB
dc.description.sponsorshipJRC.E.5-Nuclear chemistryen_GB
dc.format.mediumPrinteden_GB
dc.languageENGen_GB
dc.publisherLANDES BIOSCIENCEen_GB
dc.relation.ispartofseriesJRC33607en_GB
dc.titleIntralesional Targeted Alpha Therapy for Metastatic Melanomaen_GB
dc.typeArticles in periodicals and booksen_GB
JRC Directorate:Nuclear Safety and Security

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.